 Zachary Clayton
Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cellular Senescence | 9 | 2026 | 226 | 5.020 |
Why?
| | Vascular Stiffness | 15 | 2026 | 486 | 4.950 |
Why?
| | Doxorubicin | 7 | 2026 | 401 | 3.880 |
Why?
| | Aorta | 10 | 2026 | 440 | 3.580 |
Why?
| | Flavonols | 4 | 2026 | 27 | 3.530 |
Why?
| | Aging | 19 | 2026 | 1969 | 3.190 |
Why?
| | Endothelium, Vascular | 12 | 2026 | 956 | 2.760 |
Why?
| | Antibiotics, Antineoplastic | 4 | 2025 | 140 | 2.700 |
Why?
| | Flavonoids | 3 | 2026 | 85 | 2.690 |
Why?
| | Oxidative Stress | 11 | 2026 | 1356 | 2.490 |
Why?
| | Cardiovascular Diseases | 11 | 2026 | 2187 | 1.740 |
Why?
| | Vasodilation | 5 | 2026 | 521 | 1.610 |
Why?
| | Exercise | 9 | 2026 | 2198 | 1.600 |
Why?
| | Mice, Inbred C57BL | 16 | 2026 | 5983 | 1.520 |
Why?
| | Diet | 7 | 2024 | 1277 | 1.440 |
Why?
| | Eggs | 5 | 2021 | 25 | 1.400 |
Why?
| | Muscle, Skeletal | 7 | 2026 | 1789 | 1.280 |
Why?
| | Aniline Compounds | 3 | 2025 | 120 | 1.260 |
Why?
| | Inflammation | 12 | 2023 | 2878 | 1.210 |
Why?
| | Dietary Supplements | 6 | 2026 | 583 | 1.180 |
Why?
| | Mice | 26 | 2026 | 18329 | 1.170 |
Why?
| | Arteries | 6 | 2024 | 261 | 1.160 |
Why?
| | Pulse Wave Analysis | 10 | 2026 | 267 | 1.150 |
Why?
| | Glucose Intolerance | 2 | 2021 | 142 | 1.100 |
Why?
| | Endothelial Cells | 4 | 2026 | 874 | 1.060 |
Why?
| | Animals | 36 | 2026 | 38030 | 1.030 |
Why?
| | Insulin Resistance | 5 | 2024 | 1244 | 0.990 |
Why?
| | Mitochondria | 4 | 2026 | 992 | 0.970 |
Why?
| | Myography | 1 | 2026 | 14 | 0.960 |
Why?
| | Chemokine CXCL12 | 1 | 2026 | 86 | 0.930 |
Why?
| | Elastin | 2 | 2023 | 78 | 0.920 |
Why?
| | Aging, Premature | 1 | 2025 | 16 | 0.910 |
Why?
| | Muscular Atrophy | 1 | 2026 | 87 | 0.900 |
Why?
| | Pyruvaldehyde | 1 | 2025 | 46 | 0.890 |
Why?
| | High-Intensity Interval Training | 1 | 2025 | 45 | 0.870 |
Why?
| | Glycation End Products, Advanced | 1 | 2025 | 81 | 0.860 |
Why?
| | Work-Life Balance | 1 | 2024 | 22 | 0.840 |
Why?
| | Diet, Western | 2 | 2021 | 88 | 0.820 |
Why?
| | Spermidine | 1 | 2024 | 18 | 0.810 |
Why?
| | Vascular Diseases | 2 | 2023 | 252 | 0.800 |
Why?
| | Antioxidants | 3 | 2026 | 550 | 0.770 |
Why?
| | Obesity | 7 | 2024 | 3116 | 0.760 |
Why?
| | Motor Activity | 4 | 2024 | 718 | 0.760 |
Why?
| | Polyketides | 1 | 2022 | 5 | 0.750 |
Why?
| | Spinal Cord Injuries | 1 | 2026 | 234 | 0.730 |
Why?
| | Angiotensin II | 1 | 2022 | 101 | 0.690 |
Why?
| | Spirostans | 1 | 2021 | 4 | 0.690 |
Why?
| | Atherosclerosis | 1 | 2025 | 409 | 0.670 |
Why?
| | Blood Glucose | 4 | 2019 | 2341 | 0.670 |
Why?
| | Head-Down Tilt | 1 | 2020 | 6 | 0.640 |
Why?
| | Diet, High-Fat | 2 | 2021 | 266 | 0.630 |
Why?
| | Reactive Oxygen Species | 5 | 2024 | 611 | 0.620 |
Why?
| | Bone Density | 2 | 2021 | 487 | 0.610 |
Why?
| | Male | 30 | 2026 | 72843 | 0.600 |
Why?
| | Cognitive Dysfunction | 2 | 2022 | 467 | 0.590 |
Why?
| | Physical Conditioning, Animal | 1 | 2021 | 242 | 0.590 |
Why?
| | Prunus domestica | 1 | 2019 | 1 | 0.590 |
Why?
| | Humans | 52 | 2026 | 145475 | 0.580 |
Why?
| | Breast Neoplasms | 3 | 2026 | 2382 | 0.560 |
Why?
| | Carbon Dioxide | 1 | 2020 | 227 | 0.560 |
Why?
| | Carotid Arteries | 3 | 2025 | 208 | 0.550 |
Why?
| | Cholesterol, LDL | 2 | 2020 | 360 | 0.540 |
Why?
| | Housing, Animal | 1 | 2018 | 46 | 0.530 |
Why?
| | Adipose Tissue, Brown | 1 | 2018 | 60 | 0.530 |
Why?
| | Subcutaneous Fat | 1 | 2018 | 79 | 0.530 |
Why?
| | Neovascularization, Pathologic | 1 | 2019 | 286 | 0.520 |
Why?
| | Blood Pressure | 8 | 2026 | 1779 | 0.510 |
Why?
| | Body Temperature Regulation | 1 | 2018 | 105 | 0.510 |
Why?
| | Colonic Neoplasms | 1 | 2019 | 257 | 0.500 |
Why?
| | Neoplasms | 2 | 2022 | 2906 | 0.500 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2021 | 1217 | 0.500 |
Why?
| | Medical Laboratory Science | 1 | 2016 | 9 | 0.490 |
Why?
| | Extracellular Matrix | 1 | 2021 | 562 | 0.490 |
Why?
| | Sulfonamides | 3 | 2025 | 583 | 0.490 |
Why?
| | Physiology | 1 | 2016 | 13 | 0.480 |
Why?
| | Weight Loss | 1 | 2022 | 858 | 0.480 |
Why?
| | Cancer Survivors | 3 | 2026 | 337 | 0.480 |
Why?
| | Students, Health Occupations | 1 | 2016 | 37 | 0.470 |
Why?
| | Feeding Behavior | 2 | 2019 | 690 | 0.470 |
Why?
| | Bread | 1 | 2015 | 2 | 0.450 |
Why?
| | Brain | 3 | 2024 | 2947 | 0.450 |
Why?
| | Cardiovascular System | 1 | 2016 | 138 | 0.450 |
Why?
| | Temperature | 1 | 2018 | 633 | 0.440 |
Why?
| | Breakfast | 1 | 2015 | 20 | 0.440 |
Why?
| | Writing | 1 | 2016 | 101 | 0.440 |
Why?
| | Sympathetic Nervous System | 2 | 2026 | 181 | 0.440 |
Why?
| | Physical Conditioning, Human | 1 | 2015 | 38 | 0.430 |
Why?
| | T-Lymphocytes | 1 | 2022 | 1996 | 0.400 |
Why?
| | Educational Measurement | 1 | 2016 | 326 | 0.390 |
Why?
| | Anthracyclines | 2 | 2022 | 49 | 0.370 |
Why?
| | Nitric Oxide | 4 | 2025 | 892 | 0.370 |
Why?
| | Adipose Tissue | 3 | 2022 | 645 | 0.360 |
Why?
| | Resistance Training | 1 | 2015 | 186 | 0.360 |
Why?
| | Energy Metabolism | 1 | 2018 | 935 | 0.350 |
Why?
| | Female | 24 | 2026 | 78845 | 0.340 |
Why?
| | Cholesterol | 3 | 2019 | 408 | 0.330 |
Why?
| | Bed Rest | 2 | 2020 | 14 | 0.300 |
Why?
| | Antineoplastic Agents | 1 | 2021 | 2214 | 0.300 |
Why?
| | Lipids | 3 | 2020 | 707 | 0.290 |
Why?
| | Randomized Controlled Trials as Topic | 9 | 2023 | 1747 | 0.290 |
Why?
| | Risk Factors | 6 | 2025 | 10885 | 0.270 |
Why?
| | Clinical Competence | 1 | 2016 | 1243 | 0.270 |
Why?
| | Rats | 4 | 2026 | 5584 | 0.260 |
Why?
| | Young Adult | 9 | 2026 | 14219 | 0.260 |
Why?
| | Hand Strength | 2 | 2026 | 144 | 0.260 |
Why?
| | Eating | 3 | 2023 | 387 | 0.240 |
Why?
| | Ubiquinone | 1 | 2026 | 35 | 0.230 |
Why?
| | Transcriptome | 2 | 2023 | 1038 | 0.230 |
Why?
| | Reflex | 1 | 2026 | 70 | 0.230 |
Why?
| | Sirtuins | 1 | 2026 | 50 | 0.230 |
Why?
| | Hindlimb | 1 | 2026 | 132 | 0.230 |
Why?
| | Arterioles | 1 | 2025 | 52 | 0.230 |
Why?
| | Fertilization in Vitro | 1 | 2026 | 108 | 0.220 |
Why?
| | Trastuzumab | 1 | 2026 | 118 | 0.220 |
Why?
| | Aged | 11 | 2026 | 26153 | 0.220 |
Why?
| | Organophosphorus Compounds | 1 | 2026 | 84 | 0.220 |
Why?
| | Random Allocation | 2 | 2016 | 365 | 0.220 |
Why?
| | Bottle-Nosed Dolphin | 1 | 2024 | 3 | 0.210 |
Why?
| | Mitochondria, Muscle | 1 | 2026 | 120 | 0.210 |
Why?
| | Methylamines | 2 | 2022 | 39 | 0.210 |
Why?
| | Education, Graduate | 1 | 2024 | 35 | 0.210 |
Why?
| | Imidazoles | 1 | 2025 | 247 | 0.210 |
Why?
| | Apigenin | 1 | 2023 | 3 | 0.200 |
Why?
| | Regional Blood Flow | 1 | 2026 | 514 | 0.200 |
Why?
| | Exercise Tolerance | 1 | 2026 | 283 | 0.200 |
Why?
| | Elastic Modulus | 1 | 2024 | 121 | 0.200 |
Why?
| | Postmenopause | 1 | 2026 | 392 | 0.200 |
Why?
| | Synbiotics | 1 | 2023 | 2 | 0.200 |
Why?
| | Peripheral Vascular Diseases | 1 | 2024 | 104 | 0.200 |
Why?
| | Adult | 15 | 2026 | 40777 | 0.190 |
Why?
| | Vitis | 1 | 2023 | 28 | 0.190 |
Why?
| | Pistacia | 1 | 2023 | 2 | 0.190 |
Why?
| | Rats, Sprague-Dawley | 2 | 2026 | 2524 | 0.190 |
Why?
| | Disease Models, Animal | 3 | 2025 | 4560 | 0.190 |
Why?
| | Goals | 1 | 2024 | 184 | 0.190 |
Why?
| | Hypertension | 2 | 2023 | 1273 | 0.190 |
Why?
| | Cardiotoxicity | 1 | 2022 | 35 | 0.190 |
Why?
| | Biomarkers | 5 | 2023 | 4295 | 0.180 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2023 | 131 | 0.180 |
Why?
| | Probiotics | 1 | 2023 | 61 | 0.180 |
Why?
| | Middle Aged | 13 | 2026 | 36215 | 0.180 |
Why?
| | Career Choice | 1 | 2024 | 234 | 0.180 |
Why?
| | Social Class | 1 | 2024 | 264 | 0.180 |
Why?
| | Testosterone | 1 | 2026 | 416 | 0.180 |
Why?
| | Femur | 2 | 2021 | 254 | 0.180 |
Why?
| | Age Factors | 3 | 2024 | 3342 | 0.180 |
Why?
| | Drinking Water | 1 | 2022 | 89 | 0.170 |
Why?
| | Macular Pigment | 1 | 2021 | 3 | 0.170 |
Why?
| | Frailty | 1 | 2024 | 205 | 0.170 |
Why?
| | Laboratories | 1 | 2022 | 110 | 0.170 |
Why?
| | Sweat | 1 | 2021 | 51 | 0.160 |
Why?
| | Vision, Ocular | 1 | 2021 | 47 | 0.160 |
Why?
| | Nitrates | 1 | 2021 | 93 | 0.160 |
Why?
| | Triglycerides | 3 | 2020 | 520 | 0.160 |
Why?
| | Sodium | 1 | 2021 | 198 | 0.160 |
Why?
| | Precision Medicine | 1 | 2024 | 459 | 0.150 |
Why?
| | Honey | 1 | 2019 | 11 | 0.150 |
Why?
| | Amino Acids | 2 | 2021 | 519 | 0.150 |
Why?
| | Isoflavones | 1 | 2019 | 25 | 0.150 |
Why?
| | Insulin | 3 | 2019 | 2512 | 0.150 |
Why?
| | Rats, Wistar | 1 | 2021 | 450 | 0.150 |
Why?
| | Dietary Sugars | 1 | 2019 | 21 | 0.150 |
Why?
| | Vitamins | 1 | 2021 | 182 | 0.150 |
Why?
| | Dementia | 1 | 2024 | 327 | 0.150 |
Why?
| | Running | 1 | 2022 | 233 | 0.150 |
Why?
| | Sex Factors | 1 | 2025 | 2105 | 0.140 |
Why?
| | Blood Vessels | 1 | 2020 | 167 | 0.140 |
Why?
| | Adipokines | 1 | 2019 | 57 | 0.140 |
Why?
| | Time Factors | 3 | 2026 | 7123 | 0.140 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2018 | 8 | 0.140 |
Why?
| | Collagen | 1 | 2021 | 457 | 0.140 |
Why?
| | Postprandial Period | 1 | 2019 | 114 | 0.140 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 84 | 0.140 |
Why?
| | Hyperinsulinism | 1 | 2019 | 114 | 0.130 |
Why?
| | Ceramides | 1 | 2018 | 117 | 0.130 |
Why?
| | Osteogenesis | 1 | 2019 | 204 | 0.130 |
Why?
| | Vitamin D | 1 | 2021 | 403 | 0.130 |
Why?
| | Cholesterol, Dietary | 1 | 2016 | 15 | 0.130 |
Why?
| | Xanthophylls | 1 | 2016 | 19 | 0.130 |
Why?
| | Nutrition Policy | 1 | 2016 | 57 | 0.120 |
Why?
| | Polycystic Ovary Syndrome | 1 | 2019 | 187 | 0.120 |
Why?
| | Body Weight | 4 | 2023 | 971 | 0.120 |
Why?
| | Hot Temperature | 1 | 2019 | 396 | 0.120 |
Why?
| | Phenotype | 1 | 2024 | 3155 | 0.120 |
Why?
| | Analysis of Variance | 1 | 2019 | 1300 | 0.120 |
Why?
| | Ethanol | 1 | 2021 | 631 | 0.120 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2026 | 1963 | 0.120 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2021 | 2588 | 0.120 |
Why?
| | Cross-Over Studies | 3 | 2026 | 608 | 0.120 |
Why?
| | Heart Rate | 3 | 2026 | 855 | 0.110 |
Why?
| | Body Composition | 2 | 2020 | 693 | 0.110 |
Why?
| | Hyperglycemia | 1 | 2019 | 379 | 0.110 |
Why?
| | Critical Illness | 1 | 2021 | 900 | 0.110 |
Why?
| | Gene Expression | 1 | 2019 | 1476 | 0.110 |
Why?
| | Diabetes Mellitus | 1 | 2023 | 1097 | 0.100 |
Why?
| | Adiposity | 1 | 2019 | 532 | 0.100 |
Why?
| | Liver | 1 | 2023 | 1896 | 0.100 |
Why?
| | Overweight | 1 | 2019 | 614 | 0.100 |
Why?
| | Adolescent | 4 | 2026 | 22530 | 0.100 |
Why?
| | Circadian Rhythm | 1 | 2018 | 512 | 0.100 |
Why?
| | Energy Intake | 3 | 2020 | 512 | 0.090 |
Why?
| | Cognition | 1 | 2020 | 1266 | 0.090 |
Why?
| | Cytokines | 1 | 2019 | 2067 | 0.090 |
Why?
| | Mice, Knockout | 1 | 2018 | 3124 | 0.080 |
Why?
| | Chickens | 2 | 2021 | 179 | 0.080 |
Why?
| | Cholesterol, HDL | 2 | 2020 | 201 | 0.070 |
Why?
| | Chronic Disease | 1 | 2015 | 1808 | 0.070 |
Why?
| | Case-Control Studies | 2 | 2026 | 3623 | 0.070 |
Why?
| | Arterial Pressure | 1 | 2026 | 134 | 0.060 |
Why?
| | Brachial Artery | 1 | 2026 | 208 | 0.050 |
Why?
| | Vascular Resistance | 1 | 2026 | 370 | 0.050 |
Why?
| | Healthy Aging | 1 | 2024 | 44 | 0.050 |
Why?
| | Surveys and Questionnaires | 1 | 2016 | 6066 | 0.050 |
Why?
| | Nuts | 1 | 2023 | 13 | 0.050 |
Why?
| | Butanols | 1 | 2022 | 6 | 0.050 |
Why?
| | Hexanols | 1 | 2022 | 7 | 0.050 |
Why?
| | Models, Animal | 1 | 2024 | 393 | 0.050 |
Why?
| | Child | 1 | 2022 | 22707 | 0.050 |
Why?
| | Vasodilator Agents | 1 | 2024 | 330 | 0.050 |
Why?
| | Superoxides | 1 | 2022 | 198 | 0.040 |
Why?
| | Lutein | 1 | 2021 | 16 | 0.040 |
Why?
| | Zeaxanthins | 1 | 2021 | 19 | 0.040 |
Why?
| | Sweating | 1 | 2021 | 43 | 0.040 |
Why?
| | Body Mass Index | 2 | 2020 | 2445 | 0.040 |
Why?
| | Estrogens | 1 | 2023 | 367 | 0.040 |
Why?
| | Observational Studies as Topic | 1 | 2021 | 133 | 0.040 |
Why?
| | Rats, Zucker | 1 | 2019 | 32 | 0.040 |
Why?
| | Social Determinants of Health | 1 | 2024 | 308 | 0.040 |
Why?
| | Phytoestrogens | 1 | 2019 | 17 | 0.040 |
Why?
| | Diet, Fat-Restricted | 1 | 2020 | 79 | 0.040 |
Why?
| | Diet, Carbohydrate-Restricted | 1 | 2020 | 38 | 0.040 |
Why?
| | Osteocalcin | 1 | 2019 | 38 | 0.040 |
Why?
| | Fibroblast Growth Factors | 1 | 2021 | 188 | 0.040 |
Why?
| | Dietary Sucrose | 1 | 2019 | 50 | 0.040 |
Why?
| | Immersion | 1 | 2019 | 7 | 0.040 |
Why?
| | Anthropometry | 1 | 2020 | 206 | 0.040 |
Why?
| | Enteral Nutrition | 1 | 2021 | 217 | 0.040 |
Why?
| | United States | 1 | 2016 | 16098 | 0.040 |
Why?
| | Exercise Test | 1 | 2022 | 630 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2022 | 718 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2019 | 360 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 2019 | 422 | 0.030 |
Why?
| | Bone and Bones | 1 | 2019 | 317 | 0.030 |
Why?
| | Osteoporosis | 1 | 2019 | 238 | 0.030 |
Why?
| | Respiration, Artificial | 1 | 2021 | 713 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2019 | 776 | 0.030 |
Why?
| | Length of Stay | 1 | 2021 | 1349 | 0.030 |
Why?
| | Critical Care | 1 | 2021 | 702 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 924 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2026 | 5905 | 0.030 |
Why?
| | Pregnancy | 1 | 2026 | 7202 | 0.020 |
Why?
|
|
Clayton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|